Stocks WDH Financial statements
Financial statementsWaterdrop Inc. financial statements
Income statement, balance sheet and cash flow statement for the last 5 fiscal years, taken from the XBRL data Waterdrop Inc. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|
| Revenue | 503 | 406 | 371 | 380 | 569 |
| Research and development | 59.5 | 42.2 | 42.1 | 29.7 | 33.3 |
| Selling and marketing | 487 | 90.5 | 104 | 95.2 | 160 |
| General and administrative | 83.3 | 56.3 | 56.7 | 50.4 | 44.3 |
| Operating expenses | 795 | 337 | 371 | 355 | 516 |
| Operating income | -292 | 69.3 | -0.95 | 24.4 | 53 |
| Interest income | 7.64 | 11.8 | 19.2 | 20.4 | 19.4 |
| Other non-operating income | 1.53 | 9.7 | 4.31 | 3.47 | 5.24 |
| Pre-tax income | -282 | 91.4 | 23.1 | 49.4 | 77.7 |
| Income tax | -34.7 | 3.33 | 0.08 | 1.33 | -3.09 |
| Net income | -247 | 88.1 | 23.6 | 50.3 | 81.4 |
| EBITDA | -290 | 72.6 | 0.94 | 26 | 55 |
| EPS, basic | -0.09 | 0.02 | 0.01 | 0.01 | 0.02 |
| EPS, diluted | -0.09 | 0.02 | 0.01 | 0.01 | 0.02 |
| Shares, basic (weighted) | 2,991 | 3,921 | 3,770 | 3,651 | 3,615 |
| Shares, diluted (weighted) | 2,991 | 4,022 | 3,881 | 3,720 | 3,714 |
Balance sheet
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|
| Cash and equivalents | 128 | 228 | 55.9 | 135 | 69.1 |
| Short-term investments | 309 | 309 | 422 | 221 | 75.9 |
| Receivables | 101 | 98 | 97.6 | 98.1 | 180 |
| Other current assets | 58 | 49.7 | 26.7 | 25 | 35.9 |
| Total current assets | 790 | 825 | 764 | 635 | 569 |
| Property, plant and equipment | 7.02 | 4.55 | 4.77 | 32.9 | 36.6 |
| Lease right-of-use assets | 9.27 | 2.68 | 8.43 | 6.42 | 3.43 |
| Goodwill | 0.54 | 0.5 | 11.4 | 11.1 | 11.5 |
| Intangible assets | 8.91 | 8.21 | 25 | 21 | 25.3 |
| Long-term investments | 1.85 | 1.74 | 29.8 | 153 | 327 |
| Total assets | 824 | 859 | 866 | 884 | 1,015 |
| Deferred revenue | 0.13 | ||||
| Short-term debt | 19.4 | 27.2 | 6.72 | ||
| Total current liabilities | 196 | 163 | 193 | 203 | 271 |
| Total liabilities | 200 | 168 | 207 | 216 | 279 |
| Paid-in capital | 1,150 | 1,071 | 986 | 936 | 963 |
| Retained earnings | -523 | -395 | -361 | -301 | -232 |
| Treasury stock | -0 | -0 | -0 | ||
| Other comprehensive income | -3.37 | 15.7 | 20.3 | 21.9 | 6.24 |
| Shareholders' equity | 624 | 691 | 646 | 657 | 737 |
| Total equity | 624 | 691 | 646 | 657 | 737 |
| Total liabilities and equity | 824 | 859 | 866 | 884 | 1,015 |
| Shares outstanding | 3,943 | 3,910 | 3,702 | 3,625 | 3,609 |
Cash flow statement
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|
| Net income | 247 | 88.1 | 23.1 | 48.1 | 80.8 |
| Depreciation and amortization | 2.81 | 3.31 | 1.89 | 1.57 | 1.97 |
| Stock-based compensation | 35.5 | 16.2 | 18.9 | 11.9 | 7.4 |
| Change in receivables | -16.3 | -6.21 | 2.85 | -4.81 | -80.4 |
| Cash from operations | -172 | 111 | 57.3 | 59.9 | 34.9 |
| Capital expenditures | -5.6 | -1.72 | -1.91 | -29.9 | -4.24 |
| Purchases of investments | -2,049 | -10.1 | -1,612 | -883 | -884 |
| Cash from investing | -133 | -20.3 | -165 | 40 | -32.1 |
| Stock issued | 0.47 | 1.41 | 1.65 | 0.99 | 0.92 |
| Share buybacks | -2.6 | -9.72 | -74.1 | -14.7 | -13 |
| Dividends paid | -21.7 | -18.6 | |||
| Cash from financing | 333 | -8.33 | -53.1 | -27.2 | -53.5 |
| Exchange rate effect | -2.21 | 5.47 | 3.69 | 0.35 | -2.96 |
| Net change in cash | 25.4 | 87.9 | -157 | 73 | -53.7 |
| Free cash flow | -178 | 109 | 55.4 | 30 | 30.6 |
| Interest paid | 0.03 | 0.26 | 0.04 | ||
| Income taxes paid | 0.4 | 0.25 | 0.18 | 0.27 | 0.05 |
Key metrics
Profitability
| Metric | Value | How it is calculated |
|---|---|---|
| Operating margin | 9.3% | Operating income / revenue. |
| EBITDA margin | 9.7% | EBITDA (operating income + depreciation and amortization) / revenue. |
| Pre-tax margin | 13.7% | Pre-tax income / revenue. |
| Net margin | 14.3% | Net income / revenue. |
| FCF margin | 5.4% | Free cash flow (cash from operations - capital expenditures) / revenue. |
| Operating cash flow margin | 6.1% | Cash from operations / revenue. |
| Effective tax rate | -4.0% | Income tax / pre-tax income, when pre-tax income is positive. |
| Return on equity (ROE) | 11.7% | Net income / average shareholders' equity (opening and closing). Not shown when equity is negative. |
| Return on assets (ROA) | 8.6% | Net income / average total assets. |
| Return on invested capital (ROIC) | 7.0% | Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%. |
| R&D / revenue | 5.8% | Research and development expense / revenue. |
| Stock-based pay / revenue | 1.3% | Stock-based compensation (from the cash flow statement) / revenue. |
| Capex / revenue | 0.7% | Capital expenditures / revenue. |
| D&A / revenue | 0.3% | Depreciation and amortization / revenue. |
Growth
| Metric | Value | How it is calculated |
|---|---|---|
| Revenue growth, 1y | 49.8% | Revenue vs the same period a year earlier. Only from a positive base. |
| Revenue CAGR, 3y | 11.9% | Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Operating income growth, 1y | 117.3% | Operating income vs the same period a year earlier. Only from a positive base. |
| Operating income CAGR, 3y | -8.5% | Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| EBITDA growth, 1y | 111.8% | EBITDA vs the same period a year earlier. Only from a positive base. |
| EBITDA CAGR, 3y | -8.8% | Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Net income growth, 1y | 61.6% | Net income vs the same period a year earlier. Only from a positive base. |
| Net income CAGR, 3y | -2.6% | Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| EPS growth, 1y | 100.0% | EPS vs the same period a year earlier. Only from a positive base. |
| EPS CAGR, 3y | 0.0% | Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Operating cash flow growth, 1y | -41.8% | Operating cash flow vs the same period a year earlier. Only from a positive base. |
| Operating cash flow CAGR, 3y | -32.0% | Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Free cash flow growth, 1y | 2.2% | Free cash flow vs the same period a year earlier. Only from a positive base. |
| Free cash flow CAGR, 3y | -34.5% | Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Book value growth, 1y | 12.1% | Book value vs the same period a year earlier. Only from a positive base. |
| Book value CAGR, 3y | 2.2% | Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Total assets growth, 1y | 14.8% | Total assets vs the same period a year earlier. Only from a positive base. |
| Total assets CAGR, 3y | 5.7% | Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Share count change, 1y | -0.2% | Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 3y | -2.6% | Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution. |
Balance sheet health
| Metric | Value | How it is calculated |
|---|---|---|
| Current ratio | 2.10x | Current assets / current liabilities. |
| Quick ratio | 1.20x | (Cash + short-term investments + receivables) / current liabilities. |
| Cash ratio | 0.54x | (Cash + short-term investments) / current liabilities. |
| Liabilities / assets | 27.4% | Total liabilities / total assets. |
| Working capital | $298.6M | Current assets - current liabilities. |
| Goodwill and intangibles / assets | 3.6% | (Goodwill + intangible assets) / total assets. |
| Tangible book value | $699.8M | Shareholders' equity - goodwill - intangible assets. |
Efficiency
| Metric | Value | How it is calculated |
|---|---|---|
| Asset turnover | 0.60x | Revenue / average total assets. |
| Fixed asset turnover | 16.4x | Revenue / average property, plant and equipment. |
| Receivables turnover | 4.09x | Revenue / average receivables. |
| Days sales outstanding | 89 days | 365 x average receivables / revenue. |
| FCF conversion | 37.7% | Free cash flow / net income, when net income is positive. |
| Capex / operating cash flow | 12.1% | Capital expenditures / cash from operations, when that is positive. |
Per share
| Metric | Value | How it is calculated |
|---|---|---|
| EPS, diluted | $0.02 | Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS. |
| EPS, basic | $0.02 | Net income per basic share, as reported (split-adjusted). |
| Revenue per share | $0.15 | Revenue / diluted weighted shares. |
| FCF per share | $0.01 | Free cash flow / diluted weighted shares. |
| Operating cash flow per share | $0.01 | Cash from operations / diluted weighted shares. |
| Book value per share | $0.20 | Shareholders' equity / shares outstanding (diluted weighted shares when not reported). |
| Tangible book per share | $0.19 | Tangible book value / shares outstanding. |
| Cash per share | $0.04 | (Cash + short-term investments) / shares outstanding. |
| Payout ratio | 22.9% | Dividends paid / net income, when net income is positive. |
| Dividends / FCF | 60.9% | Dividends paid / free cash flow, when free cash flow is positive. |
| Buybacks / FCF | 42.6% | Share buybacks / free cash flow, when free cash flow is positive. |
Valuation
| Metric | Value | How it is calculated |
|---|---|---|
| Market cap | $373.7M | Share price x shares outstanding. |
| Enterprise value | $228.7M | Market cap + total debt - cash - short-term investments. |
| P/E | 4.59x | Market cap / net income. Only when net income is positive. |
| P/S | 0.66x | Market cap / revenue. |
| P/B | 0.51x | Market cap / shareholders' equity. Only when equity is positive. |
| Price / tangible book | 0.53x | Market cap / tangible book value, when positive. |
| P/FCF | 12.2x | Market cap / free cash flow. Only when free cash flow is positive. |
| P/OCF | 10.7x | Market cap / cash from operations, when positive. |
| EV/Sales | 0.40x | Enterprise value / revenue. |
| EV/EBIT | 4.31x | Enterprise value / operating income, when both are positive. |
| EV/EBITDA | 4.16x | Enterprise value / EBITDA, when both are positive. |
| EV/FCF | 7.46x | Enterprise value / free cash flow, when both are positive. |
| FCF yield | 8.2% | Free cash flow / market cap. |
| Earnings yield | 21.8% | Net income / market cap (the inverse of P/E). |
| Dividend yield | 5.0% | Dividends paid over the period / market cap. |
| Shareholder yield | 8.5% | (Dividends paid + share buybacks) / market cap. |
What was Waterdrop Inc.'s revenue in fiscal 2025?
Waterdrop Inc. reported revenue of $568.8M for fiscal 2025, 49.8% higher than the year before.
Was Waterdrop Inc. profitable in fiscal 2025?
Yes. Net income was $81.4M, a net margin of 14.3%.
How much free cash flow did Waterdrop Inc. generate in fiscal 2025?
Cash from operations of $34.9M minus capital expenditures of $4.2M left free cash flow of $30.6M.